SLC25A10 and cancer: It was reported to be highly expressed in most human cancers (e.g., thyroid, colorectal, prostate, ovarian, etc.), and is strongly associated with poor cancer prognosis [33].SLC25A10 is upregulated in a variety of tumors and is involved in regulating intracellular levels of reactive oxygen species.